Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants.

Clinical and translational science·2026

Same author

Unravelling the human disposition of [<sup>14</sup>C]-vebreltinib: Faecal recovery of parent drug and a major circulating metabolite defines its mass balance profile.

British journal of clinical pharmacology·2026

Same author

The Molecular Interplay Between Helicobacter pylori Infection and Ulcerative Colitis: Unraveling Shared Biomarkers and Pathway Networks.

Immunity, inflammation and disease·2026

Same author

Trends in drug-drug interactions for new drug clinical trials in China over the past 10 years (2013-2022).

BMC pharmacology & toxicology·2025

Same author

Changes in Early-Phase Clinical Trials in China During 2013-2022: A Review.

Drugs in R&D·2024

Same author

An open-label study to explore the optimal design of CYP3A drug-drug interaction clinical trials in healthy Chinese people.

Pharmacology research & perspectives·2024

Search research articles

Related Experiment Video

Updated: Jun 12, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Immunothrombosis: A bibliometric analysis from 2003 to 2023.

Mengyu Hou¹, Jingxuan Wu, Jiangshuo Li

¹Department of Research Ward, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

|September 17, 2024

Summary

This bibliometric study analyzes immunothrombosis research, revealing key topics like platelets, inflammation, and COVID-19. It highlights trends in understanding and treating thrombotic disorders.

More Related Videos

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

Related Experiment Videos

Last Updated: Jun 12, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

Area of Science:

Medical research
Biomedical science
Thrombosis research

Background:

Immunothrombosis is an intravascular innate immune response.
Dysregulated immunothrombosis contributes to thrombotic disorders.
COVID-19 has intensified research into immunothrombosis mechanisms and thrombotic events.

Purpose of the Study:

To conduct a bibliometric analysis of immunothrombosis research.
To identify current status, research hotspots, and future trends in the field.
To provide a comprehensive overview for researchers.

Main Methods:

Collected 495 papers from Web of Science (2003-2023).
Utilized VOSviewer and R package 'Bibliometrix' for analysis.
Analyzed publication metrics, keywords, and research trends.

Main Results:

Research spans 58 countries, involving 3287 authors and 1011 institutions.
Key topics include platelets, inflammation, neutrophil extracellular traps, Von Willebrand factor, and complement system.
Hotspots focus on COVID-19-related immunothrombosis and treatments for cardiovascular/cerebrovascular diseases.

Conclusions:

Bibliometric analysis offers a summary of immunothrombosis research achievements.
Identifies development trends and guides future research directions.
Provides a comprehensive understanding of the immunothrombosis research landscape.